697 related articles for article (PubMed ID: 17705011)
1. Diffuse and diffuse-plus-focal uptake in the thyroid gland identified by using FDG-PET: prevalence of thyroid cancer and Hashimoto's thyroiditis.
Kurata S; Ishibashi M; Hiromatsu Y; Kaida H; Miyake I; Uchida M; Hayabuchi N
Ann Nucl Med; 2007 Aug; 21(6):325-30. PubMed ID: 17705011
[TBL] [Abstract][Full Text] [Related]
2. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
Karantanis D; Bogsrud TV; Wiseman GA; Mullan BP; Subramaniam RM; Nathan MA; Peller PJ; Bahn RS; Lowe VJ
J Nucl Med; 2007 Jun; 48(6):896-901. PubMed ID: 17504869
[TBL] [Abstract][Full Text] [Related]
5. Huge thyroid uptake of 18F-FDG in a patient with Hashimoto's thyroiditis referred for a malignant thyroid lesion.
Yoshihara A; Isozaki O; Okubo Y; Maki M; Kusakabe K; Takano K
Thyroid; 2008 May; 18(5):579-80. PubMed ID: 18407754
[No Abstract] [Full Text] [Related]
6. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of patterns of increased [
Tsubaki F; Kurata S; Tani J; Sumi A; Fujimoto K; Abe T
Jpn J Radiol; 2018 Mar; 36(3):181-193. PubMed ID: 29280068
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with the development of new onset diffuse thyroid F18-fluorodeoxyglucose uptake after treatment of breast cancer in patients without a history of thyroid disease or thyroid dysfunction.
Kim SS; Kim SJ; Bae YT; Lee JY; Kim BH; Kim YK; Kim IJ
Thyroid; 2012 Jan; 22(1):53-8. PubMed ID: 22142373
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects.
Kang KW; Kim SK; Kang HS; Lee ES; Sim JS; Lee IG; Jeong SY; Kim SW
J Clin Endocrinol Metab; 2003 Sep; 88(9):4100-4. PubMed ID: 12970270
[TBL] [Abstract][Full Text] [Related]
11. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Ho TY; Liou MJ; Lin KJ; Yen TC
Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
[TBL] [Abstract][Full Text] [Related]
14. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
[TBL] [Abstract][Full Text] [Related]
15. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
[TBL] [Abstract][Full Text] [Related]
16. "Focal thyroid inferno" on color Doppler ultrasonography: a specific feature of focal Hashimoto's thyroiditis.
Fu X; Guo L; Zhang H; Ran W; Fu P; Li Z; Chen W; Jiang L; Wang J; Jia J
Eur J Radiol; 2012 Nov; 81(11):3319-25. PubMed ID: 22608398
[TBL] [Abstract][Full Text] [Related]
17. Chronic thyroiditis: diffuse uptake of FDG at PET.
Yasuda S; Shohtsu A; Ide M; Takagi S; Takahashi W; Suzuki Y; Horiuchi M
Radiology; 1998 Jun; 207(3):775-8. PubMed ID: 9609903
[TBL] [Abstract][Full Text] [Related]
18. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism.
Rothman IN; Middleton L; Stack BC; Bartel T; Riggs AT; Bodenner DL
Eur Arch Otorhinolaryngol; 2011 Oct; 268(10):1501-4. PubMed ID: 21327732
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
20. Hashimoto's thyroiditis and papillary thyroid carcinoma. Are cytokeratin 19 and P63 proteins of any diagnostic value?
Divani SN; Kalodimos GP; Lioupis MA; Syrmos NC
Hell J Nucl Med; 2016; 19(3):250-253. PubMed ID: 27824965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]